Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
DIA’s Canadian Pharmacovigilance and Risk Management Conference is the premier place to hear from expert pharmaceutical, biotechnology, and regulatory personnel. The latest updates in pharmacovigilance, risk management, and drug safety will be presented from both a global and a tailored Canadian perspective.
Need approval in order to attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.Travel Once, Learn Twice
Receive $150 off your registration fee when you register for this meeting and the co-located DIA Annual Canadian Meeting.
Check out our 2019 Program!
Featured
Who should attend?
Learning objectives
- Describe recent regulatory agency initiatives in Canada, Europe, and the US, to strengthen pharmacovigilance and risk management efforts within their respective regions
- Discuss recent updates to the Canada Vigilance database and perspectives of Health Canada and industry on opportunities and challenges that these changes pose
- Compare and contrast pharmacovigilance inspections by Health Canada, MHRA, and FDA, and discuss recent findings from Health Canada inspections
- Discuss Health Canada and industry perspectives on current pharmacovigilance risk management requirements and best practices in Canada
Program Committee
-
Rita Cassola, RPh • Executive Director PV
Certus PV Services Inc, Canada -
Marcia Bailey, BSN, MHS, RN • Safety Evaluation & Risk Management Scientific Director
GSK, Canada -
Colin D'Cunha, MD, MHS, FRCPC • Director, Global Medical Affairs
Apotex Inc., Canada -
Mélanie Derry, PhD • Associate Director
Health Canada, Canada -
Marc Poitras, PhD, MBA • Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada
Contact us
Registration Questions?
Check out our 2019 Program!
On Demand Content Preview Webinar
Cybersecurity and Implications for Pharmacovigilance